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1. INTRODUCTION 2. MATERIALS AND METHODS 
The Ca2+ pumping ATPase purified from the 
erythrocyte membrane can be stimulated by cal- 
modulin, by a number of acidic phospholipids, by 
polyunsaturated fatty acids, and by a limited pro- 
teolytic treatment [l-3]. Phenothiazine neurolep- 
tics inhibit the Ca2+-pumping ATPase in red cells 
[4]. This is in agreement with the finding [4,5] that 
phenothiazines bind to calmodulin and inhibit its 
interaction with a variety of enzyme targets. A 
number of so-called anti-calmodulin drugs have 
since been shown to inhibit the Ca2+-pumping 
ATPase of red cells, the most notable in terms of 
potency, being the derivative of the antimycotic 
miconazole R2457 1 [6]. 
The Ca2+-ATPase was purifed as in [ 11, and 
reconstituted in asolectin or phosphatidylcholine, 
essentially by the cholate dialysis procedure in [2]. 
The lipid-cholate-ATPase mixture was dialysed 
overnight at 4°C against 500-2000 vol. 120 mM 
KCl, 10 mM Hepes (pH 7.2), 50 PM MgCl2 and 
1 mM dithiothreitol. 
We have repeatedly observed that phenothia- 
zines and R24571 block the stimulation of the 
purified Ca2+ ATPase, or of the reconstituted 
purified Ca2+ -ATPase by calmodulin. However, 
these two compounds also remove the activation of 
ATPase by the alternative treatments mentioned 
above. This unexpected observation may be very 
important to the problem of whether calmodulin 
and the other alternative activating treatments act 
by the same mechanism or not, and is described in 
some detail here. 
Abbreviations: Hepes, 4-(2-hydroxyethl)- I-piperazine 
ethanesulfonic acid; EGTA, ethylene glycol bis(amino- 
ethyl ether) iV,N,N’,N’-tetraacetic acid; HEDTA, N-(hy- 
droxyethl) ethylenediamine-N,N’,N’-triacetic acid; 
DMSO, dimethylsulfoxide; TFP, trifluoperazine 
The ATPase activity was monitored spectrophoto- 
metrically by the coupled-enzyme assay in (21, in a 
medium containing, in 1 ml final vol. at 37”C, 120 
mM KCl, 60 mM Hepes (pH 7.0), 1 mM MgCl2,0.5 
mM K2-ATP, 0.2 mM NADH, 0.5 mM phospho- 
enolpyruvate, 1 IU ofpyruvate kinase, 1 IU oflactate 
dehydrogenase 500 PM EGTA, 500 PM HEDTA, 
0.5 PM A23187, the amounts of calmodulin speci- 
tied in the figure legends (when added), and 600 PM 
CaCl2 (total free Ca2+, 10 PM). After 4 min incu- 
bation, the reaction was started with the addition of 
the purified or reconstituted ATPase (2-5 mg pro- 
tein corresponding to 25-30 al liposomal suspen- 
sion). Under these conditions, the rate of ATP hy- 
drolysis was linear for a considerable time. The 
unstimulated activity is defined here as the activity 
in the presence of phosphatidylcholine (added 
phospholipid or liposomes) but in the absence of: 
(a) calmodulin; or (b) proteolytic treatment. In the 
case of phosphatidylserine, the stimulation by the 
latter is defined here as the increment in ATPase 
activity with respect to a sample incubated and 
assayed under identical conditions but in the pres- 
ence of phosphatidylcholine instead of phosphatidyl- 
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serine. Appropriate controls showed that the drugs 
tested inhibited the unstimulated ATPase only 
negligibly. 
The activation of the non-reconstituted 
Ca*+-ATPase by phosphatidylserine (fig. 1) was 
studied on the enzyme isolated in the presence of 
0.05% Triton X-100 and 0.05% phosphatidylchol- 
ine. Phosphatidylserine or phosphatidylcholine 
were microdispersed as indicated in [2] and added 
at 10 pg/pg enzyme protein. 
Proteolysis was performed on 50 ~1 phosphati- 
dylcholine-reconstituted vesicles (see above) with 2 
pg trypsin for 3 min at 37°C. The proteolytic reac- 
tion was stopped by the addition of 10 r_lg soybean 
trypsin inhibitor. After 2 min on ice, the proteolyzed 
enzyme was added to the preincubated ATPase 
assay medium. 
Protein was precipitated using deoxycholate and 
trichloroacetic acid to avoid interference with, e.g., 
Hepes [8] and determined as in [9]. 
All reagents were of the highest purity available. 
The phospholipids were grade I, from Lipids Prod- 
ucts (South Nuftield). Calmodulin was isolated 
from bovine brain [lo]. Trypsin and soybean trypsin 
inhibitor were obtained from Calbiochem-Behring 
(La Jolla CA). R 24571 was a kind gift of Dr Van 
Belle, Janssen Pharmaceuticals (Beerse) and was 
dissolved in DMSO. Trifluoperazine was a kind gift 
of Smith, Kline and French (Philadelphia PA), and 
was dissolved in 5 mM HCl. 
3. RESULTS AND DISCUSSION 
Fig.1 shows that the potent anticalmodulin drug 
R24571 blocks the activation of the purified ATP- 
ase by calmodulin: half-maximal inhibition was 
observed at 3 PM R2457 1, and complete inhibition at 
8 PM. In a series of 4 experiments of this type, the 
variability range for the KI/, was 3-6 PM, and for 
100% inhibition 8-10 PM. In fig. 1, 1 pg calmodulin 
was used. Under identical experimental conditions, 
the inhibition curve was shifted somewhat to the 
right if 1.5 PLg calmodulin were used. R2457 1 remov- 
ed the stimulation of the ATPase induced by 
phosphatidylserine in the absence of calmodulin. 
The degree of activation of the ATPase was the 
same in the case of calmodulin and phosphatidyl- 
serine, but the amount of R2457 1 required for 50% 
and 100% inhibition of the activation was greater in 
the latter case. This, however, may reflect the pos- 
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Fig.]. Effect of R24571 on the activation of the purified 
erythrocyte Ca 2+-ATPase by calmodulin or by phos- 
phatidylserine. Details are described in section 2: 
1 pg calmodulin present; (o) phosphatidylserine; (0) cal- 
modulin (phosphatidylcholine). 
sible preferential binding of R24571 to phosphati- 
dylserine. 
Fig.2-4 show the effect of trifluo 
activation of the reconstituted P 
erazine on the 
Ca +-ATPase by 
either calmodulin (phosphatidylcholine liposomes) 
acidic phospholipids (asolectin liposomes), or con- 
trolled proteolysis (phosphatidylcholine lipo- 
somes). The acidic phospholipid in this case was 
cardiolipin, which represents - 15% of the phospho- 
lipids of asolectin. It is evident from ftg.l-4 that 
trifluoperazine counteracted very efficiently not 
only the activation produced by calmodulin, but 
also that produced by acidic phospholipids and by 
limited proteolysis. Varying amounts of liposomal 
phospholipids were added to the reaction media. 
Since trifluoperazine partitions into organic phases, 
it was important to compare its effects on the acti- 
vations by calmodulin, asolectin, and limited pro- 
teolysis at equivalent amounts of phospholipids 
added to the medium. Fig.2 (o), fig.3 (A) and fig.4 
(o) compare the effects obtained by adding 25-30 
~1 phospholipids. Under these conditions (i.e.. 
equivalent amounts of phospholipids) the inhibi- 
tion curves in the case of calmodulin and asolectin 
appeared similar and reached 100% over 150-100 
PM, whereas the kinetics of the inhibition in the 
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Fig.%. Effect of trifluoperazine on the activation of the 
reconstituted Ca2+-ATPase by calmodulin. Details are 
described in section 2: pg calmodulin was present; (0) 25 
~1 phosphatidylcholine liposomes; (o) 50 ~1 phosphati- 
dylcholine liposomes. 
case of limited proteolysis differed significantly. 
The activation decreased more rapidly than in the 
case of calmodulin and asolectin at low trifluoper- 
azine concentrations, but more slowly at higher 
concentrations. The end-values never reached 100% 
in the range of trifluoperazine concentrations tested 
(up to 250 PM). At equivalent phospholipids con- 
centrations, the amount of trifluoperazine required 
for 50% and 100% inhibition (asolectin and calmo- 
dulin) were - IO-times higher than those of 
R2457 1, and increased progressively as the amount 
of liposomes in the medium increased (tig.2,3). This 
was observed also in the case of limited proteolysis 
(fig.4). Evidently, the drug became non-specifically 
bound to the phospholipids of the liposomes. 
Two anticalmodulin drugs interfere with the ac- 
tivation of the purified or reconstituted Ca2+-ATP- 
ase of erythrocytes by alternative, calmodulin- 
unrelated treatments. The finding has obvious rele- 
vance to the problem of the mechanism of stimula- 
tion of the Ca2+-ATPase by calmodulin. More 
TFP &M) 
Fig.3. Effect of trifluoperazine on the activation of the 
reconstituted Ca2+-ATPase by asolectin. Details are 
described in section 2: 1 pg calmodulin was present; (A) 
50 ~1 asolectin’liposomes; (A) 30 ~1 asolectin liposomes; 
(0) 30 ~1 asolectin liposomes; (0) 10 ~1 asolectin 
liposomes. 
specifically, the finding is relevant to the question of 
whether calmodulin and the other alternative acti- 
vating treatments act by the same mechanism. 
Taking the problem one step further, one can ask 
the question of whether anticalmodulin compounds 
act on calmodulin only, or interact with the ATP- 
ase molecule also. While it is now accepted that 
phenothiazines interact directly with calmodulin 
(see [ 111, our evidence now indicates that pheno- 
thiazines bind to the Ca2+-ATPase as well. 
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Fig.4. Effect of trifluoperazine on the activation of the 
reconstituted Ca2+-ATPase by limited proteolysis. 
Details are described in section 2: 1 pg calmodulin 
was present; (0) 50 ~1 phosphatidylcholine liposomes; 
(o) 25 ~1 phosphatidylcholine liposomes. 
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